Nonlean NAFLD patients had significantly different effect estimates than lean NAFLD patients in cardio metabolic profiles: BMI (mean difference, P‐value: 5.62 kg/m2, P < 0.001), WC (16.44 cm, P < 0.001), SBP (4.97 mmHg, P < 0.001), DBP (3.45 mmHg, P < 0.001), FBS (3.37 mg/dL, P < 0.001), HbA1c (0.14%, P = 0.02), HOMA‐IR (1.07, P < 0.001), HDL (−3.12 mg/dL, P < 0.001), TG (13.07 mg/dL, P = 0.001), UA (0.37 mg/dL, P = 0.003), ALT (5.66 U/L, P < 0.001), AST (3.31 U/L, P < 0.001), and GGT (4.58 U/L, P = 0.027). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.